These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25254647)

  • 1. Glutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats.
    Potter MC; Wozniak KM; Callizot N; Slusher BS
    PLoS One; 2014; 9(9):e102936. PubMed ID: 25254647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of the glutamate carboxypeptidase II inhibitor 2-MPPA show prolonged alleviation of neuropathic pain through an indirect mechanism.
    Vornov JJ; Wozniak KM; Wu Y; Rojas C; Rais R; Slusher BS
    J Pharmacol Exp Ther; 2013 Sep; 346(3):406-13. PubMed ID: 23776202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.
    Majer P; Jackson PF; Delahanty G; Grella BS; Ko YS; Li W; Liu Q; Maclin KM; Poláková J; Shaffer KA; Stoermer D; Vitharana D; Wang EY; Zakrzewski A; Rojas C; Slusher BS; Wozniak KM; Burak E; Limsakun T; Tsukamoto T
    J Med Chem; 2003 May; 46(10):1989-96. PubMed ID: 12723961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice.
    Takatsu Y; Fujita Y; Tsukamoto T; Slusher BS; Hashimoto K
    Brain Res; 2011 Jan; 1371():82-6. PubMed ID: 21093418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiospecificity of glutamate carboxypeptidase II inhibition.
    Tsukamoto T; Majer P; Vitharana D; Ni C; Hin B; Lu XC; Thomas AG; Wozniak KM; Calvin DC; Wu Y; Slusher BS; Scarpetti D; Bonneville GW
    J Med Chem; 2005 Apr; 48(7):2319-24. PubMed ID: 15801825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy.
    Zhang W; Murakawa Y; Wozniak KM; Slusher B; Sima AA
    J Neurol Sci; 2006 Sep; 247(2):217-23. PubMed ID: 16780883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain.
    Majer P; Hin B; Stoermer D; Adams J; Xu W; Duvall BR; Delahanty G; Liu Q; Stathis MJ; Wozniak KM; Slusher BS; Tsukamoto T
    J Med Chem; 2006 May; 49(10):2876-85. PubMed ID: 16686531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
    Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW
    J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of pyridoxine-induced peripheral neuropathy by Cichorium intybus hydroalcoholic extract through GABAergic system.
    Hasannejad F; Ansar MM; Rostampour M; Mahdavi Fikijivar E; Khakpour Taleghani B
    J Physiol Sci; 2019 May; 69(3):465-476. PubMed ID: 30712095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of glutamate in diabetic and in chemotherapy induced peripheral neuropathies and its regulation by glutamate carboxypeptidase II.
    Carozzi VA; Ceresa C
    Curr Med Chem; 2012; 19(9):1261-8. PubMed ID: 22304715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in the discovery and development of glutamate carboxypeptidase II inhibitors.
    Tsukamoto T; Wozniak KM; Slusher BS
    Drug Discov Today; 2007 Sep; 12(17-18):767-76. PubMed ID: 17826690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxine-induced neuropathy in rats: a sensory neuropathy that responds to 4-methylcatechol.
    Callizot N; Warter JM; Poindron P
    Neurobiol Dis; 2001 Aug; 8(4):626-35. PubMed ID: 11493027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.
    Carozzi VA; Chiorazzi A; Canta A; Lapidus RG; Slusher BS; Wozniak KM; Cavaletti G
    Neurotox Res; 2010 May; 17(4):380-91. PubMed ID: 19763734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy.
    Wozniak KM; Wu Y; Vornov JJ; Lapidus R; Rais R; Rojas C; Tsukamoto T; Slusher BS
    J Pharmacol Exp Ther; 2012 Dec; 343(3):746-54. PubMed ID: 22988061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.
    Perry T; Holloway HW; Weerasuriya A; Mouton PR; Duffy K; Mattison JA; Greig NH
    Exp Neurol; 2007 Feb; 203(2):293-301. PubMed ID: 17125767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.
    Sanabria ER; Wozniak KM; Slusher BS; Keller A
    J Neurophysiol; 2004 Jan; 91(1):182-93. PubMed ID: 12917384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration.
    Rais R; Wozniak K; Wu Y; Niwa M; Stathis M; Alt J; Giroux M; Sawa A; Rojas C; Slusher BS
    PLoS One; 2015; 10(7):e0131861. PubMed ID: 26151906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effects of glutamate in pyridoxine-induced neuropathy.
    Arkaravichien T; Sattayasai N; Daduang S; Sattayasai J
    Food Chem Toxicol; 2003 Oct; 41(10):1375-80. PubMed ID: 12909271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain.
    Chen SR; Wozniak KM; Slusher BS; Pan HL
    J Pharmacol Exp Ther; 2002 Feb; 300(2):662-7. PubMed ID: 11805230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats.
    Long JB; Yourick DL; Slusher BS; Robinson MB; Meyerhoff JL
    Eur J Pharmacol; 2005 Jan; 508(1-3):115-22. PubMed ID: 15680261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.